J. Ganjei
Director/Board Member at INMUNE BIO, INC.
Net worth: 192 876 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Moss | M | 54 | 9 years | |
| Moon-Jong Noh | M | 56 | 23 years | |
| Mark Lowdell | M | 61 | 9 years | |
| Raymond Tesi | M | 68 | 9 years | |
| Marcia Allen | F | 73 | 5 years | |
| Scott Juda | M | 53 | 6 years | |
| Edgardo Baracchini | M | 64 | 5 years | |
| Michael Stella | M | - |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 17 years |
| Steven H. Kasok | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 4 years |
| Timothy Schroeder | M | 66 | 8 years | |
| Shaun Rodriguez | M | - |
Amplifybio LLC
 Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | - |
| Rohan Nirody | M | - |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | - |
| Matt Vaughan | M | - |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | - |
| Greg Kastner | M | - |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | 3 years |
| Joshua S. Schoonover | M | - | - | |
| Scott Law | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 7 years |
| Lori Noffsinger | F | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 22 years |
| Evis Hursever | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Paul H. MuIIan | M | - |
University of Maryland
| 29 years |
| Lewis von Thaer | M | 63 |
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | - |
| Katherine Turner | F | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 22 years |
| Roger Kang | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Jean-Christophe Renondin | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Michael J. Warmuth | M | 61 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Tara Lehner | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ana María Ibáñez Londoño | M | 54 |
University of Maryland
| 5 years |
| Kamil Yilmaz | M | - |
University of Maryland
| 5 years |
| Timothy Johnson | M | - |
University of Maryland
| 6 years |
| Arun Raghupathy | M | 55 |
University of Maryland
| 4 years |
| Deepak Gupta | M | - |
University of Maryland
| 3 years |
| Rajiv Laroia | M | 61 |
University of Maryland
| 4 years |
| Bikash Koley | M | 50 |
University of Maryland
| 5 years |
| Timothy Moore | M | 62 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Sanjay Shukla | M | 52 |
University of Maryland
| 5 years |
| Victor Gao | M | - |
University of Maryland
| 3 years |
| Stanley P. Kinder | M | - |
University of Maryland
| 14 years |
| Peter R. Culpepper | M | 64 |
University of Maryland
| 2 years |
| Dave W. McClarin | M | - |
University of Maryland
| 4 years |
| Brent Luers | M | - |
University of Maryland
| 4 years |
| Joseph M. Wrobleski | M | - |
University of Maryland
| 4 years |
| Daniel Webster Keogh | M | - |
University of Maryland
| 3 years |
| Michael Daugard | M | - |
University of Maryland
| 4 years |
| John Schierman | M | - |
University of Maryland
| 3 years |
| Tabetha A. Baume-Chandler | F | - |
University of Maryland
| 4 years |
| Nicole G. Minnick | F | - |
University of Maryland
| 4 years |
| Robert L. Barr | M | - |
University of Maryland
| 4 years |
| John Andrew McCarthy | M | 60 |
University of Maryland
| 3 years |
| Hai Ying Zhao | M | 59 |
University of Maryland
| 3 years |
| Shawn M. Ruehl | M | - |
University of Maryland
| 4 years |
| Tracey Jubeck | F | - |
University of Maryland
| 5 years |
| Eugene Bredow | M | 54 |
University of Maryland
| 4 years |
| Sang Na | M | - |
University of Maryland
| 5 years |
| John Patrick Keenan | M | - |
University of Maryland
| 4 years |
| Judy Lapinski | M | - |
University of Maryland
| 3 years |
| Gregory J. Star | M | - |
University of Maryland
| 4 years |
| Tarun Khanna | M | 53 |
University of Maryland
| 4 years |
| Anas Abuzaakouk | M | 47 |
University of Maryland
| 4 years |
| Mario Eisenberger | M | 74 |
University of Maryland
| 9 years |
| David Szymkowski | M | 60 | 3 years | |
| Joseph Huddle | M | - |
University of Maryland
| 4 years |
| Holly Majka | F | - |
University of Maryland
| 5 years |
| Daaiyah Threats | F | - |
University of Maryland
| - |
| Scott C | M | - |
University of Maryland
| 5 years |
| Youlee K. Nishimura | F | - |
University of Maryland
| 4 years |
| Amit Tilak Mehta | M | - |
University of Maryland
| 2 years |
| Daniel Rochkind | M | 48 |
University of Maryland
| 4 years |
| Cindy Rose Quackenbush | F | - |
University of Maryland
| 4 years |
| Vivien Liu | F | - |
University of Maryland
| 4 years |
| Martin Friedman | M | 73 |
University of Maryland
| 3 years |
| Shane Kim | M | 47 |
University of Maryland
| 4 years |
| Thomas David Teles | M | - |
University of Maryland
| 4 years |
| Kay L. Kim | F | - |
University of Maryland
| 3 years |
| Paul Brandeis | M | - |
University of Maryland
| 4 years |
| Peter Yared | M | - |
University of Maryland
| 6 years |
| Adam B. Steel | M | - |
University of Maryland
| 1 years |
| Robert W. Henley | M | 57 |
University of Maryland
| 4 years |
| Laura A. Evans | F | - |
University of Maryland
| 4 years |
| Adam Eisenberg | M | - |
University of Maryland
| 4 years |
| Natalia Sokolova | F | 48 |
University of Maryland
| 4 years |
| Sujal Patel | M | 49 |
University of Maryland
| 4 years |
| Stuart Schwartz | M | - |
University of Maryland
| 4 years |
| Carol Anne Huff | F | - |
University of Maryland
| 3 years |
| Jill Taymans | F | 55 |
University of Maryland
| 4 years |
| Michael W. Jarmolowich | M | - |
University of Maryland
| 4 years |
| Tzu-Lung Chao | M | - |
University of Maryland
| 4 years |
| Matt Theurer | M | - |
University of Maryland
| 4 years |
| John Hanna | M | - |
University of Maryland
| 4 years |
| Sab Kanaujia | M | - |
University of Maryland
| 2 years |
| Mark P. Elless | M | - |
University of Maryland
| 3 years |
| Allan Michael Budelman | M | - |
University of Maryland
| 4 years |
| Meetesh V. Patel | M | 49 |
University of Maryland
| 4 years |
| David K. Rensin | M | - |
University of Maryland
| 4 years |
| Steven H. Krein | M | - |
University of Maryland
| 4 years |
| Ajoy Mallik | M | - |
University of Maryland
| 4 years |
| Jesús Pérez de Uriguen | M | 53 |
University of Maryland
| 4 years |
| Alex Brecher | M | 46 |
University of Maryland
| 4 years |
| Nicholas Enukidze | M | 54 |
University of Maryland
| 2 years |
| Frank Taylor Shull | M | - |
University of Maryland
| 4 years |
| Qin Si Zhao | M | 60 |
University of Maryland
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- J. Ganjei
- Personal Network
